Enhancing the Victorian Community Based Pharmacotherapy System: Future Directions Thomas Roszkowski Operations, Mental Health Drugs & Regions Department of Health

Policy drivers Victorian Pharmacotherapy Review (September 2010) VAGO review ‘Managing Drug and Alcohol Prevention & Treatment Services’ (March 2011) Budget - $11m over 4 yrs … and beyond, recurrent New directions for AOD treatment services: a roadmap (June 2012) Whole of Government Victorian AOD Strategy Revised policy for maintenance pharmacotherapy for opioid dependence Review of the Specialist Pharmacotherapy Services 2013

Future Directions facilitation, not clinical service delivery area based pharmacotherapy networks local knowledge and an ability to facilitate strategic partnerships to affect change strong leadership and sound strategy a whole system approach incorporates a systems integration approach /partnerships enhance clinical support in the network area and facilitate close working relationship with addiction medicine specialist

Pharmacotherapy network area teams a team structure in each of the five network areas configured to include existing resources (which may need to be realigned to better fit the model) and new resources exact team composition may vary depending on the specific needs and requirements within each network area structures will be further informed by the submissions received as part of the tender process executive/ leader role in each of the network areas, will manage the team and budget, and lead a strategic response to the specific needs identified in the network area

The case for change Victorian Pharmacotherapy Review findings Referral pathways – will support pathways between specialist and primary care and promote shared care into service operations Insufficient treatment places – support to service providers, with strategies to recruit new prescribers and dispensing pharmacies (greater spread and coverage with lower caseloads) Workforce development – new training, strengthening addiction medicine specialisation, including scholarship funding Quality of care – focus on pain management; promoting clinical guidelines to assess stability for unsupervised dosing

Short, medium and long term outcomes Short term outcomes (2013) Medium term outcomes ( ) Long term outcomes ( ) Finalisation of SPS review Development of specs/measures Model commissioning and rollout Evaluation framework developed 2013/14 consolidation of teams 2013/14 alignment with AOD treatment sector reforms 2014 each network team to develop and commence implementation of a local strategy/action plan 2014 commencement of evaluation 2015 monitoring progress against KPIs and model adjustment to meet emerging needs Ongoing monitoring of system responsiveness to client needs Responding to emerging needs Adopting latest best practice clinical approach Monitor real impact on practice, partnerships in regions, engagement of pharmacies and GPs, linkages to broader AOD treatment sector and alignment to AOD reforms and the Victorian AOD Strategy.

Questions & discussion Contact details: Dr Thomas Roszkowski, Operations, Mental Health Drugs & Regions Department of Health Telephone: